Our very own Chief Scientific Officer, Dr. Judi Quilici Timmcke, and her colleague, Dr. Sergej Ostojić recently published a study on some groundbreaking findings in molecular hydrogen. They recently presented their research at the American Society for Nutrition’s (ASN) annual flagship meeting, NUTRITION 2024, in Chicago, Illinois.
Their study, titled Medium-Term Intake of Dihydrogen and Pyrroloquinoline Quinone Affects Brain Metabolism and Cognition in Elderly Cognitive Impairment, revealed promising results. Dr. Timmcke and Dr. Ostojić found that the combination of dihydrogen and PQQ may significantly improve cognitive function and brain metabolism in elderly individuals with mild cognitive impairment. These initial results are encouraging, paving the way for further research into the benefits of molecular hydrogen and PQQ as dietary supplements.
For those interested in learning even more, you can access the full study here.
